Protocol Summaries

Links to protocol summaries of current & upcoming clinical trials at the Case site

March 2019

Coming Soon:

5359:  A phase III randomized, cross-over study to evaluate long-acting injectable antiretroviral therapy for people living with HIV who have not been adherent to their antiretroviral therapy in pill form. A5359 Provider Summary

5377: A Phase I, First-in-Human, Ascending Dose Study of SAR441236, a Tri-specific Broadly Neutralizing Antibody, in Participants with HIV. A5377 Provider Summary